Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 3 clinical trials
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

randomized to the active (anastrozole) or control (placebo) group. Anastrozole 1 mg tablet / day will be self-administered with or without food, at around the same time every day (active group); placebo 1

body mass index
klinefelter syndrome
testosterone level
androgen deficiency
  • 24 Mar, 2022
  • 1 location
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

This phase II trial studies how well anastrozole and letrozole after surgery work in treating patients with stage I-III breast cancer. Drugs, such as anastrozole and letrozole, may stop the growth of tumor cells by decreasing the amount of estrogen made by the body. Giving anastrozole and letrozole after surgery …

blood estrogen
estrogen receptor
neutrophil count
tumor cells
  • 16 Jun, 2022
  • 3 locations
GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

More than three quarter of patients with breast cancer are treated by hormone pills called tamoxifen and aromatase inhibitors (AIs). AIs are drugs that stop female hormone production. This hormone production mostly happens in fat, muscle, and breast tissue in postmenopausal women. The female hormone estrogen is an important hormone …

primary tumor
breast cancer staging
core needle biopsy
  • 13 May, 2022
  • 1 location